Dr Chad Michael Kaplan, MD - Medicare Ophthalmology in Coral Springs, FL

Dr Chad Michael Kaplan, MD is a medicare enrolled "Ophthalmology" physician in Coral Springs, Florida. He went to University Of Florida College Of Medicine and graduated in 2011 and has 13 years of diverse experience with area of expertise as Ophthalmology. He is a member of the group practice Henry Alexander Spratt Md Pa and his current practice location is 6280 W Sample Rd Ste 202, Coral Springs, Florida. You can reach out to his office (for appointments etc.) via phone at (561) 322-3588.

Dr Chad Michael Kaplan is licensed to practice in Florida (license number ME128229) and he also participates in the medicare program. He may accept medicare assignments (which means he may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance) and his NPI Number is 1841580214.

Contact Information

Dr Chad Michael Kaplan, MD
6280 W Sample Rd Ste 202,
Coral Springs, FL 33067-3173
(561) 322-3588
(561) 322-3589



Physician's Profile

Full NameDr Chad Michael Kaplan
GenderMale
SpecialityOphthalmology
Experience13 Years
Location6280 W Sample Rd Ste 202, Coral Springs, Florida
Accepts Medicare AssignmentsMay be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Chad Michael Kaplan attended and graduated from University Of Florida College Of Medicine in 2011
  NPI Data:
  • NPI Number: 1841580214
  • Provider Enumeration Date: 04/19/2011
  • Last Update Date: 10/15/2021
  Medicare PECOS Information:
  • PECOS PAC ID: 2769795392
  • Enrollment ID: I20210913000303

Medical Identifiers

Medical identifiers for Dr Chad Michael Kaplan such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1841580214NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207W00000XOphthalmology ME128229 (Florida)Primary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Henry Alexander Spratt Md Pa22647139735

News Archive

FDA approves Teligent's sNDA for CEFOTAN (cefotetan) for Injection

Teligent, Inc., a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company's supplemental new drug application (sNDA) from the U.S. Food and Drug Administration (FDA) for CEFOTAN (cefotetan) for Injection.

New understanding of biological effects of alcohol on genes within cells

Alcohol triggers the activation of a variety of genes that can influence the health and activity of brain cells, and new research from Weill Cornell Medical College in New York City sheds light on how that process occurs.

National poll examines public health response to anthrax attack

In a national poll aimed at helping with planning efforts for a public health response to a possible bioterrorism attack, researchers at the Harvard School of Public Health (HSPH) have found that, in response to a fictional scenario describing a significant anthrax attack in their city or town, most Americans (89%) will likely follow public health recommendations to obtain prophylactic antibiotics.

Cypin protein may prevent long-term brain damage after stroke

One of two proteins that regulate nerve cells and assist in overall brain function may be the key to preventing long-term damage as a result of a stroke, the leading cause of disability and third leading cause of death in the United States.

Paracetamol effective for chronic pain and arthritis

A research team from University of Queensland has just published the results of a small study into the effectiveness of medications for chronic pain.

Read more Medical News

› Verified 9 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Chad Michael Kaplan allows following entities to bill medicare on his behalf.
Entity NameFlorida Eye & Plastic Surgery Associates Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1467497529
PECOS PAC ID: 9638195787
Enrollment ID: O20051019000055

News Archive

FDA approves Teligent's sNDA for CEFOTAN (cefotetan) for Injection

Teligent, Inc., a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company's supplemental new drug application (sNDA) from the U.S. Food and Drug Administration (FDA) for CEFOTAN (cefotetan) for Injection.

New understanding of biological effects of alcohol on genes within cells

Alcohol triggers the activation of a variety of genes that can influence the health and activity of brain cells, and new research from Weill Cornell Medical College in New York City sheds light on how that process occurs.

National poll examines public health response to anthrax attack

In a national poll aimed at helping with planning efforts for a public health response to a possible bioterrorism attack, researchers at the Harvard School of Public Health (HSPH) have found that, in response to a fictional scenario describing a significant anthrax attack in their city or town, most Americans (89%) will likely follow public health recommendations to obtain prophylactic antibiotics.

Cypin protein may prevent long-term brain damage after stroke

One of two proteins that regulate nerve cells and assist in overall brain function may be the key to preventing long-term damage as a result of a stroke, the leading cause of disability and third leading cause of death in the United States.

Paracetamol effective for chronic pain and arthritis

A research team from University of Queensland has just published the results of a small study into the effectiveness of medications for chronic pain.

Read more Medical News

› Verified 9 days ago

Entity NameGregory R Cohen Md Pa
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1396948352
PECOS PAC ID: 3971696261
Enrollment ID: O20070831000332

News Archive

FDA approves Teligent's sNDA for CEFOTAN (cefotetan) for Injection

Teligent, Inc., a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company's supplemental new drug application (sNDA) from the U.S. Food and Drug Administration (FDA) for CEFOTAN (cefotetan) for Injection.

New understanding of biological effects of alcohol on genes within cells

Alcohol triggers the activation of a variety of genes that can influence the health and activity of brain cells, and new research from Weill Cornell Medical College in New York City sheds light on how that process occurs.

National poll examines public health response to anthrax attack

In a national poll aimed at helping with planning efforts for a public health response to a possible bioterrorism attack, researchers at the Harvard School of Public Health (HSPH) have found that, in response to a fictional scenario describing a significant anthrax attack in their city or town, most Americans (89%) will likely follow public health recommendations to obtain prophylactic antibiotics.

Cypin protein may prevent long-term brain damage after stroke

One of two proteins that regulate nerve cells and assist in overall brain function may be the key to preventing long-term damage as a result of a stroke, the leading cause of disability and third leading cause of death in the United States.

Paracetamol effective for chronic pain and arthritis

A research team from University of Queensland has just published the results of a small study into the effectiveness of medications for chronic pain.

Read more Medical News

› Verified 9 days ago

Entity NameKendall Eye Institute Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1639367261
PECOS PAC ID: 2769562560
Enrollment ID: O20080107000385

News Archive

FDA approves Teligent's sNDA for CEFOTAN (cefotetan) for Injection

Teligent, Inc., a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company's supplemental new drug application (sNDA) from the U.S. Food and Drug Administration (FDA) for CEFOTAN (cefotetan) for Injection.

New understanding of biological effects of alcohol on genes within cells

Alcohol triggers the activation of a variety of genes that can influence the health and activity of brain cells, and new research from Weill Cornell Medical College in New York City sheds light on how that process occurs.

National poll examines public health response to anthrax attack

In a national poll aimed at helping with planning efforts for a public health response to a possible bioterrorism attack, researchers at the Harvard School of Public Health (HSPH) have found that, in response to a fictional scenario describing a significant anthrax attack in their city or town, most Americans (89%) will likely follow public health recommendations to obtain prophylactic antibiotics.

Cypin protein may prevent long-term brain damage after stroke

One of two proteins that regulate nerve cells and assist in overall brain function may be the key to preventing long-term damage as a result of a stroke, the leading cause of disability and third leading cause of death in the United States.

Paracetamol effective for chronic pain and arthritis

A research team from University of Queensland has just published the results of a small study into the effectiveness of medications for chronic pain.

Read more Medical News

› Verified 9 days ago

Entity NameSouth Florida Vision Associates Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1275949653
PECOS PAC ID: 7810119674
Enrollment ID: O20141111000306

News Archive

FDA approves Teligent's sNDA for CEFOTAN (cefotetan) for Injection

Teligent, Inc., a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company's supplemental new drug application (sNDA) from the U.S. Food and Drug Administration (FDA) for CEFOTAN (cefotetan) for Injection.

New understanding of biological effects of alcohol on genes within cells

Alcohol triggers the activation of a variety of genes that can influence the health and activity of brain cells, and new research from Weill Cornell Medical College in New York City sheds light on how that process occurs.

National poll examines public health response to anthrax attack

In a national poll aimed at helping with planning efforts for a public health response to a possible bioterrorism attack, researchers at the Harvard School of Public Health (HSPH) have found that, in response to a fictional scenario describing a significant anthrax attack in their city or town, most Americans (89%) will likely follow public health recommendations to obtain prophylactic antibiotics.

Cypin protein may prevent long-term brain damage after stroke

One of two proteins that regulate nerve cells and assist in overall brain function may be the key to preventing long-term damage as a result of a stroke, the leading cause of disability and third leading cause of death in the United States.

Paracetamol effective for chronic pain and arthritis

A research team from University of Queensland has just published the results of a small study into the effectiveness of medications for chronic pain.

Read more Medical News

› Verified 9 days ago

Entity NameHenry Alexander Spratt Md Pa
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1013461904
PECOS PAC ID: 2264713973
Enrollment ID: O20170111000548

News Archive

FDA approves Teligent's sNDA for CEFOTAN (cefotetan) for Injection

Teligent, Inc., a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company's supplemental new drug application (sNDA) from the U.S. Food and Drug Administration (FDA) for CEFOTAN (cefotetan) for Injection.

New understanding of biological effects of alcohol on genes within cells

Alcohol triggers the activation of a variety of genes that can influence the health and activity of brain cells, and new research from Weill Cornell Medical College in New York City sheds light on how that process occurs.

National poll examines public health response to anthrax attack

In a national poll aimed at helping with planning efforts for a public health response to a possible bioterrorism attack, researchers at the Harvard School of Public Health (HSPH) have found that, in response to a fictional scenario describing a significant anthrax attack in their city or town, most Americans (89%) will likely follow public health recommendations to obtain prophylactic antibiotics.

Cypin protein may prevent long-term brain damage after stroke

One of two proteins that regulate nerve cells and assist in overall brain function may be the key to preventing long-term damage as a result of a stroke, the leading cause of disability and third leading cause of death in the United States.

Paracetamol effective for chronic pain and arthritis

A research team from University of Queensland has just published the results of a small study into the effectiveness of medications for chronic pain.

Read more Medical News

› Verified 9 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Chad Michael Kaplan is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Chad Michael Kaplan, MD
6280 W Sample Rd Ste 202,
Coral Springs, FL 33067-3173

Ph: (561) 322-3588
Dr Chad Michael Kaplan, MD
6280 W Sample Rd Ste 202,
Coral Springs, FL 33067-3173

Ph: (561) 322-3588

News Archive

FDA approves Teligent's sNDA for CEFOTAN (cefotetan) for Injection

Teligent, Inc., a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company's supplemental new drug application (sNDA) from the U.S. Food and Drug Administration (FDA) for CEFOTAN (cefotetan) for Injection.

New understanding of biological effects of alcohol on genes within cells

Alcohol triggers the activation of a variety of genes that can influence the health and activity of brain cells, and new research from Weill Cornell Medical College in New York City sheds light on how that process occurs.

National poll examines public health response to anthrax attack

In a national poll aimed at helping with planning efforts for a public health response to a possible bioterrorism attack, researchers at the Harvard School of Public Health (HSPH) have found that, in response to a fictional scenario describing a significant anthrax attack in their city or town, most Americans (89%) will likely follow public health recommendations to obtain prophylactic antibiotics.

Cypin protein may prevent long-term brain damage after stroke

One of two proteins that regulate nerve cells and assist in overall brain function may be the key to preventing long-term damage as a result of a stroke, the leading cause of disability and third leading cause of death in the United States.

Paracetamol effective for chronic pain and arthritis

A research team from University of Queensland has just published the results of a small study into the effectiveness of medications for chronic pain.

Read more News

› Verified 9 days ago


Ophthalmology Doctors in Coral Springs, FL

Dr. Leon Albert Bynoe, M.D.
Ophthalmology
Medicare: Accepting Medicare Assignments
Practice Location: 1881 N. University Dr., Ste. 112, Coral Springs, FL 33071
Phone: 954-755-4633    Fax: 954-755-4637
Dr. Neerav Neel Lamba, M.D.
Ophthalmology
Medicare: May Accept Medicare Assignments
Practice Location: 6280 W Sample Rd Ste 202, Coral Springs, FL 33067
Phone: 561-322-3588    Fax: 754-812-5993
Cindy Hernandez, D.O.
Ophthalmology
Medicare: Accepting Medicare Assignments
Practice Location: 8130 Royal Palm Blvd, Ste 101, Coral Springs, FL 33065
Phone: 954-340-1500    Fax: 954-753-8309
Dr. Norman Michael Kline, MD
Ophthalmology
Medicare: Medicare Enrolled
Practice Location: 1801 N University Dr, Suite 102, Coral Springs, FL 33071
Phone: 954-344-0999    Fax: 954-344-7929
Dr. Donald R Woods, M.D.
Ophthalmology
Medicare: Accepting Medicare Assignments
Practice Location: 7886 West Sample Rd, Coral Springs, FL 33065
Phone: 954-752-6465    Fax: 954-752-6591
Dr. Henry E. Glick, DO
Ophthalmology
Medicare: Accepting Medicare Assignments
Practice Location: 3100 Coral Hills Dr, Suite #206, Coral Springs, FL 33065
Phone: 954-575-4711    Fax: 954-575-4722
Dr. Robert Dale Cole, MD
Ophthalmology
Medicare: Not Enrolled in Medicare
Practice Location: 4818 Nw 58th Ave, Coral Springs, FL 33067
Phone: 903-654-0653    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.